Related Experiment Video
Updated: Jun 30, 2026

Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
Complete recovery after fulminant myocarditis in a patient with COVID-19
Vasiliki Kitsou1, Torbjørn Lunde2, Atle Solholm3
1Vasiliki Kitsou, Department of Heart Disease, Emergency Care Clinic, Haukeland University Hospital, Bergen, Norway.
Insights
Coronavirus disease 2019 (COVID-19) can cause severe myocarditis. This case study shows successful treatment and recovery from life-threatening COVID-19 myocarditis, highlighting potential therapeutic approaches.
Area of Science:
- Cardiology
- Infectious Diseases
- Virology
Background:
- Coronavirus disease 2019 (COVID-19) presents a wide clinical spectrum, from asymptomatic cases to severe multiorgan dysfunction.
- Cardiovascular complications, including myocarditis, are recognized manifestations of COVID-19.
- The pathophysiology of COVID-19-related myocarditis is not fully understood, with theories including direct viral invasion and immune-mediated cardiac damage.
Observation:
- A male patient in his early fifties presented with severe, life-threatening myocarditis during a COVID-19 infection.
- The patient's condition required intensive medical intervention.
Findings:
- The patient successfully recovered from the severe COVID-19-related myocarditis without any lasting sequelae.
- This case demonstrates a positive outcome following treatment for a critical cardiac complication of COVID-19.
Implications:
- Further research into the pathophysiology of COVID-19 myocarditis is warranted.
- Establishing clear management guidelines for COVID-19-related myocarditis is crucial.
- This case offers insights into potential successful treatment strategies for severe COVID-19 myocarditis.
Abstract:
The clinical spectrum of Coronavirus disease 2019 (COVID-19) varies from asymptomatic infection to severe disease with multiorgan dysfunction. Cardiovascular involvement is common and in rare cases can lead to serious complications, such as fulminant myocarditis. The clinical course of COVID-19 myocarditis varies from complete recovery to death in rare cases. The pathophysiology of COVID-19-related myocarditis is still unclear but is believed to involve direct viral injury and cardiac damage due to the host's immune response. Guidelines on the management of COVID-19-related myocarditis are yet to be established. We present here the case of a male patient in his early fifties admitted with life-threatening myocarditis in the course of COVID-19 infection who was successfully treated and recovered without any sequelae.
More Related Videos
Related Concept Videos
Endocarditis III: Medical Management
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Pericarditis III: Medical Management

